SillaJen sillajen.com

SillaJen is a clinical-stage biotherapeutics company that focuses on the development and commercialization of oncolytic immunotherapy products for cancer. The Company develops Pexa-Vec, an oncolytic immunotherapy to selectively infect and replicate in cancer cells by exploiting the genetic changes that frequently occur in cancer.

SillaJen is a clinical-stage biotherapeutics company that focuses on the development and commercialization of oncolytic immunotherapy products for cancer. The Company develops Pexa-Vec, an oncolytic immunotherapy to selectively infect and replicate i...Show all

See All Exits Recent Exits

Phone: +82(51) 517-7550

Fax:

6F, 252, Geumjeong-ro
Geumjeong-gu
Busan, 46274
South Korea

SillaJen - Investments & Acquisitions

Show Real Data SillaJen Investments
See all Recent Investments
Date Company Round Amount Co-investors
2014-03-18Jennerex BiotherapeuticsAcquired
See all 1 investments